Corpus Intelligence IC Memo — TENNOVA HEALTHCARE - TURKEY CREEK MC 2026-04-26 06:40 UTC
IC Memo — TENNOVA HEALTHCARE - TURKEY CREEK MC
Investment Committee Memorandum | TN | 219 beds | Grade C | EBITDA uplift $24.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

TENNOVA HEALTHCARE - TURKEY CREEK MC

CCN 440120 | KNOX, TN | 219 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

TENNOVA HEALTHCARE - TURKEY CREEK MC is a 219-bed suburban community hospital in KNOX, TN with $326.2M in net patient revenue and a 8.1% operating margin. The hospital serves a payer mix of 23.2% Medicare, 0.9% Medicaid, and 75.9% commercial.

Thesis: Platform Growth. Our ML models identify $24.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 8.1% to 15.4% (+736bps).

Net Revenue HCRIS$326.2M
Current EBITDA COMPUTED$26.4M
Operating Margin COMPUTED8.1%
Occupancy HCRIS87.5%
Revenue / Bed COMPUTED$1.5M
Net-to-Gross HCRIS13.3%
Distress Probability ML36.9%

2. Market Context & Competitive Position

141
TN Hospitals
-0.6%
State Median Margin
30
Comparable Hospitals

TN has 141 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of 8.1% places it above the state median. Among 30 size-comparable peers (110-438 beds), the median margin is 1.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (110-438), prioritizing same-state peers. 30 hospitals in the comp set.

HospitalStateBedsRevenueMargin
TENNOVA HEALTHCARE - TURKEY CR (Target)TN219$326.2M8.1%
MEMORIAL HEALTH CARE SYSTEM INTN431$583.9M-9.0%
SAINT THOMAS RUTHERFORD HOSPITTN354$447.4M1.3%
PARKRIDGE MEDICAL CENTERTN396$433.4M30.1%
REGIONAL ONE HEALTHTN291$407.9M-50.0%
PARKWEST MEDICAL CENTERTN361$396.4M-5.5%
COOKEVILLE REGIONAL MEDICAL CETN212$372.5M2.1%
SKYLINE MEDICAL CENTERTN350$360.4M15.1%
FORT SANDERS REGIONAL MEDICAL TN304$346.2M-9.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $24.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$6.9M+210bp18mo
Cost to Collect4.5%2.5%$6.5M+200bp12mo
Denial Rate Reduction12.0%6.5%$6.5M+198bp12mo
A/R Days Reduction5200.0%3800.0%$4.0M+122bp9mo
Clean Claim Rate88.0%96.0%$209K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$6.9M
Cost to Collect
$6.5M
Denial Rate Reduction
$6.5M
A/R Days Reduction
$4.0M
Clean Claim Rate
$209K
Total EBITDA Uplift$24.0M
Current EBITDA$26.4M
+ RCM Uplift+$24.0M
Pro Forma EBITDA$50.4M
Current Margin8.1%
Pro Forma Margin15.4%
WC Released (1x)$12.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$40.5M$414.0M10.21x59.2%
Base (11x exit)10.0x11.0x$40.5M$468.5M11.56x63.1%
Bull Case9.0x11.0x$36.5M$560.9M15.37x72.7%
Bull (12x exit)9.0x12.0x$36.5M$622.7M17.07x76.4%
Bear Case11.0x10.0x$44.6M$280.7M6.29x44.5%
Bear (11x exit)11.0x11.0x$44.6M$323.3M7.25x48.6%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 30 hospitals with 110-438 beds
  • Same-state prioritization (n=31)
  • Comp margins: P25=-7.7% / P50=1.8% / P75=12.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.